Press Releases Press Releases Year None20222021202020192018201720162015 Jun 14, 2022 InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin Conditions Jun 09, 2022 InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector Jun 06, 2022 InMed Pharmaceuticals Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules Jun 02, 2022 InMed Pharmaceuticals Announces $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules May 13, 2022 InMed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business Update May 05, 2022 InMed to Supply Rare Cannabinoids to Radicle Science’s “Radicle Energy Study” to Assess the Health Effects of THCV Apr 28, 2022 InMed Expands Patent Portfolio with Novel Cannabinoid Analogs and Advances Collaboration Agreement with Leading Cannabinoid Research Expert Apr 21, 2022 InMed Commercializes Cannabidivarin (CBDV), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector Apr 19, 2022 InMed to Participate in Upcoming Investor Conferences in April and May 2022 Mar 17, 2022 InMed Announces Management Changes Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page › Last page » Displaying 1 - 10 of 207 Investor Alerts Sign up for investor alerts! Sign Up Information Request Send us a request for information Learn More
Press Releases Year None20222021202020192018201720162015 Jun 14, 2022 InMed Announces Publication of Peer-Reviewed Study Highlighting Potential Role of Rare Cannabinoids THCV, CBC and others on Skin Conditions Jun 09, 2022 InMed Launches THCV, Expanding its Portfolio of Rare Cannabinoids for the Health and Wellness Sector Jun 06, 2022 InMed Pharmaceuticals Announces Closing of $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules Jun 02, 2022 InMed Pharmaceuticals Announces $5 Million Registered Direct and Private Placement Offerings Priced At-The-Market Under Nasdaq Rules May 13, 2022 InMed Pharmaceuticals Reports Third Quarter Fiscal 2022 Financial Results and Provides Business Update May 05, 2022 InMed to Supply Rare Cannabinoids to Radicle Science’s “Radicle Energy Study” to Assess the Health Effects of THCV Apr 28, 2022 InMed Expands Patent Portfolio with Novel Cannabinoid Analogs and Advances Collaboration Agreement with Leading Cannabinoid Research Expert Apr 21, 2022 InMed Commercializes Cannabidivarin (CBDV), Expanding its Rare Cannabinoid Portfolio for the Health and Wellness Sector Apr 19, 2022 InMed to Participate in Upcoming Investor Conferences in April and May 2022 Mar 17, 2022 InMed Announces Management Changes Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page › Last page » Displaying 1 - 10 of 207